|
[1]Andrade RJ, Lucena MI, Fernandez MC.Drug-induced liver inju-ry:an analysis of461incidences submitted to the Spanish registry o-ver a10-year period[J].Gastroenterology, 2005, 129 (2) :512-521.
|
|
[2]《肝博士》编辑部.药物性肝损害病死率位居全球第五[J].肝博士, 2006 (5) :68-69.
|
|
[3]Kaplowitz N.Drug-induced liver disorders:implications for drug Development and regulation[J].Drug Saf, 2001, 24:483-490.
|
|
[4]李治, 苏华, 冷静.国内外药物性肝损害状况分析[J].东南国防医药, 2007, 9 (6) :476-480.
|
|
[5]Wolters LM, Van Buuren HR.Rosuvastatin-associated hepatitis with autoimmune features[J].Eur J Gastroenterol Hepatol, 2005, 17:589-590.
|
|
[6] 萬谷直, 传统草药 (“汉方药”) 与药物性肝损害[J].日本医学介绍, 2006, 27 (6) :264.
|
|
[7]姚光弼.重视中药和草药引起的肝损害[J].肝脏, 2005, 10:1.
|
|
[8]彭学莲, 李长生, 崔苏镇.中药致肝损害文献计量分析[J].时珍国医国药, 1999, 10 (5) :392-393.
|
|
[9]Lewis JH.Drug-induced liver disease[J].The Medical clinics of North America, 2000, 84 (5) :1275-1311.
|
|
[10]曹永芬, 李雪梅, 钟琴.抗甲状腺素药物致肝损害13例报告[J].贵州医药, 2001, 25 (7) :650-651.
|
|
[11]三桥知明, 于会经 (译) , 姚桢 (校) .抗甲状腺药与药物性肝损害[J].日本医学介绍, 2006, 27 (6) :271-273.
|
|
[12]陈成伟.药物性肝病的发病机制及诊治[J].肝脏, 2007, 12 (4) :297-302.
|
|
[13]Fromenty B, Pessayre D.Inhibition of mitochondriaβ-oxidation as a mechanism of hepatotoxicity[J].Phsrmacol Ther, 1995, 67 (2) :107.
|
|
[14]郑玉娟, 冼建中, 唐小平, 等.191例药物肝病患者的临床分析[J].中华肝脏病杂志, 2003, 11 (7) :390.
|
|
[15]刘小玲.常用药物致肝损害临床分析[J].医药论坛杂志, 2003, 24 (16) :15-16.
|
|
[16]Marino G, Lewis JH.Drug-induced liver disease[J].Curr Opin Gastroenterol, 2001, 17 (3) :232-241.
|
|
[17]陈世耀, 蒋晓渠, 刘天舒, 等.药物性肝病的病因和临床表现[J].中华肝脏病杂志, 2000, 4:244.
|
|
[18]顾德正.氟哌酸致肝损害34例报告[J].苏州医学院学报, 1995, 15 (3) :472.
|
|
[19]于云朋, 黎安平.诺氟沙星致药物性肝炎1例[J].人民军医, 2004, 47 (8) :496.
|
PDF下载 ( 167 KB)
本文二维码
下载:
